
Releases
Investors Face August Deadline in ADMA Biologics Securities Lawsuit
Investors who purchased ADMA Biologics, Inc. securities between August 9, 2024, and March 25, 2026, face an August 10, 2026, deadline to serve as lead plaintiff in a pending class action lawsuit filed by The Rosen Law Firm regarding allegations of securities fraud.























